Botulinum toxin type A: all 754 studies that test it

Page 4 of 8. Open to participants first (87), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical DystoniaCompletedNCT00564681Phase 2Results posted
• BOTOX® Economic Spasticity Trial (BEST)CompletedNCT00549783Phase 4Results posted
• Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)TerminatedNCT00529386Phase 1Results posted
• Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical DystoniaCompletedNCT00528541Phase 4Results posted
• Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown LinesCompletedNCT00512135Phase 3Results posted
• Botox for Non-surgical Lateral Release in Patellofemoral PainTerminatedNCT00496964Phase 3Results posted
• Botulinum Toxin to Treat Restless Legs SyndromeCompletedNCT00479154Phase 1/2Results posted
• IncobotulinumtoxinA (Xeomin) for Upper Limb SpasticityCompletedNCT00465738Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00461292Phase 3Results posted
• Botulinum Toxin Injection for the Management of BPHCompletedNCT00451191Phase 2Results posted
• Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar FasciitisCompletedNCT00447876Phase 2/3Results posted
• Study to Assess the Efficacy and Safety of Dysport® in Cervical DystoniaCompletedNCT00447772Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderTerminatedNCT00439140Phase 3Results posted
• IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper LimbCompletedNCT00432666Phase 3Results posted
• Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical DystoniaTerminatedNCT00432341Phase 4Results posted
• IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical DystoniaCompletedNCT00407030Phase 3Results posted
• IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of BlepharospasmCompletedNCT00406367Phase 3Results posted
• Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA)CompletedNCT00403273Phase 2Results posted
• Placebo Controlled Trial of Botulinum Toxin for GastroparesisCompletedNCT00372970Not applicableResults posted
• A Multi-Center Trial of Botox for Severe Urge Urinary IncontinenceCompletedNCT00345332Not applicableResults posted
• Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.CompletedNCT00320281Phase 4Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00311376Phase 3Results posted
• Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical DystoniaCompletedNCT00288509Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT00284518Phase 2Results posted
• Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical DystoniaCompletedNCT00257660Phase 3Results posted
• Botox as a Treatment for Interstitial Cystitis in WomenCompletedNCT00194610Phase 4Results posted
• Comparative Efficacy of Three Preparations of Botox-A in Treating SpasticityCompletedNCT00178646Phase 4Results posted
• A Research Study for Patients With Overactive BladderCompletedNCT00168454Phase 2Results posted
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesCompletedNCT00168428Phase 3Results posted
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesCompletedNCT00156910Phase 3Results posted
• Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung FunctionCompletedNCT00076687Phase 2Results posted
• A Randomized Double-Blind Clinical Study of Intracavernosal OnabotulinumtoxinA Injection in Patients With Erectile Dysfunction Refractory to Phosphodiesterase-5 InhibitorsCompletedNCT07834164Phase 2
• Botulinum Toxin A for Jaw Dystonia .CompletedNCT07792798Phase 1
• Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival DisplayCompletedNCT07715331Not applicable
• Vertical Facial Morphology and Occlusal Force Changes After Masseter Botulinum Toxin Injection in BruxismCompletedNCT07673471Not applicable
• Outcome of Treatment With Botulinum toxinA in Patients With Temporomandibular Myofascial PainCompletedNCT07668375Phase 4
• BOTOX Injection Technique for LUTS Due to BPHCompletedNCT07645456Phase 1
• Comparative Evaluation of Intraneuroma and Perineuroma Botulinum Toxin Type A Injection Techniques for Chronic Neuroma Pain After Combat-Related AmputationCompletedNCT07624877Not applicable
• Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines.CompletedNCT07622004Phase 3
• Comparison of Botulinum Toxin Injection and Lateral Internal Sphincterotomy in Chronic Anal Fissure ManagementCompletedNCT07568314Not applicable
• Ultrasonographic Evaluation of Masseter Muscle Changes After Botulinum Toxin Injection in Bruxism PatientsCompletedNCT07545200Not applicable
• Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore ImprovementCompletedNCT07526870Not applicable
• Arthrocentesis-PRF Versus Botulinum Toxin for Management of ADDwRCompletedNCT07385742Not applicable
• Management of Bruxism in Patients With Implant OverdentureCompletedNCT07361900Phase 1
• Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug DeliveryCompletedNCT07360483Not applicable
• Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.CompletedNCT07137234Not applicable
• Comparison of Two Botox Injection Techniques to Improve GaitCompletedNCT07124806Not applicable
• Ultrasound-Guided Botulinum Toxin A Injection for TMJ Disc Displacement With ReductionCompletedNCT07076355Not applicable
• A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineActive, not recruitingNCT07018713Phase 3
• A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigraineActive, not recruitingNCT07018700Phase 3
• A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar LinesCompletedNCT06946160Phase 3
• Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or NotCompletedNCT06899438Not applicable
• Efficiency of Botulinum Toxin type-a in the Management of the Myofascial PainCompletedNCT06840730Not applicable
• A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial PainActive, not recruitingNCT06814535Phase 2/3
• The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid TreatmentActive, not recruitingNCT06814288Phase 2
• Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and IndependenceActive, not recruitingNCT06811142Early Phase 1
• A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult ParticipantsCompletedNCT06794866Phase 3
• Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar FascitisActive, not recruitingNCT06788158Phase 1
• Impact of OnabotulinumtoxinA (BOTOX®) on StressCompletedNCT06778421Phase 1
• Biofeedback Therapy Versus Botox Injection in Treatment of Dyssynergic Defecation.CompletedNCT06724250Phase 4
• Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and TextureCompletedNCT06604832Phase 1
• Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral PalsyCompletedNCT06583343Phase 4
• Treatment of Frostbite Sequelae With Botulinum Toxin AWithdrawnNCT06460194Phase 2
• Effectiveness of Botulinum Toxin A in Preventing Scar Formation and Initial Exploration of "Optimal Concentration"CompletedNCT06437912Early Phase 1
• Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in DystoniaActive, not recruitingNCT06411028Phase 4
• Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar LinesCompletedNCT06411002Phase 2
• A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsCompletedNCT06399718Phase 3
• A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle ProminenceCompletedNCT06387394Phase 3
• Botulinum Toxin Injection in the UES for R-CPDActive, not recruitingNCT06356025Phase 4
• A Dosage-dependent Manner of Botulinum Toxin Type A on the Prevention of Postoperative Scars of Various Anatomic Regions of the BodyCompletedNCT06349733Early Phase 1
• Intradermal BoNT-A Treatment in Erythematotelangiectatic RosaceaCompletedNCT06331533Phase 4
• Botulinum Toxin-A for Hidradenitis SuppurativaWithdrawnNCT06237465Phase 4
• DaxibotulinimtoxinA for Treatment of Platysmal Neck BandsCompletedNCT06225492Phase 4
• Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral PalsyCompletedNCT06218316Not applicable
• A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult ParticipantsCompletedNCT06174688Phase 3
• A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult ParticipantsCompletedNCT06137287Phase 3
• A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve InjuryCompletedNCT06091020Phase 2
• A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsCompletedNCT06068855Phase 3
• A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in AdultsActive, not recruitingNCT06047457Phase 3
• A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsActive, not recruitingNCT06047444Phase 3
• Xeomin vs Botox for Treatment of Overactive Bladder SyndromeStatus unknownNCT06034288Phase 2
• A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPDCompletedNCT06003049Phase 2
• To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric HypertrophyActive, not recruitingNCT05964257Phase 3
• Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb SpasticityTerminatedNCT05956509Phase 1
• The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity SpasticityWithdrawnNCT05887479Phase 4
• Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder SymptomsActive, not recruitingNCT05878951Phase 2/3
• Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary IncontinenceActive, not recruitingNCT05806164Phase 4
• Efficacy of Botulinum Toxin in Temporomandibular DisordersCompletedNCT05651256Phase 2/3
• The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled TrialCompletedNCT05650645Phase 2
• A Study to Evaluate Satisfaction in Adult Participants With the Aesthetics of the Periorbital Area After JUVÉDERM® Fillers and BOTOX®/VISTABEL® InjectionsCompletedNCT05647551Phase 4
• The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep BruxismCompletedNCT05620316Not applicable
• Comparison of Botulinum Toxin Injection Techniques in SpasticityStatus unknownNCT05615987Phase 4
• A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation TechniqueWithdrawnNCT05606757Phase 2
• A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery MethodsCompletedNCT05585398Phase 1
• Effect of Botox Injection in Anterior Belly of Digastric on Skeletal Relapse Following Mandibular Advancement SurgeryStatus unknownNCT05573581Phase 3
• Reduced-dose Botox for Urgency Incontinence Among Elder FemalesActive, not recruitingNCT05512039Phase 1/2
• Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain SyndromeActive, not recruitingNCT05485207Early Phase 1
• Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin ACompletedNCT05466539Phase 4
• A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar LinesCompletedNCT05463965Phase 3
• Transvaginal Botulinum Toxin A Chemodenervation for Overactive BladderCompletedNCT05463822Early Phase 1

← Botulinum toxin type A overview